Polycythaemia Vera and Essential Thrombocythaemia: Current Treatment Strategies

Author： Penninga Elisabeth I.   Bjerrum Ole W.  

Publisher： Adis International

ISSN： 0012-6667

Source： Drugs, Vol.66, Iss.17, 2006-01, pp. : 2173-2187

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Polycythaemia Vera and Essential Thrombocythaemia in the Elderly: Epidemiology, Management and Outcomes

By van Genderen P.J.J.   Troost M.M.  

Drugs & Aging, Vol. 17, Iss. 2, 2000-08 ,pp. : 107-119

Adis International

Access to resources Recommend Favorite

Current treatment practice for essential thrombocythaemia in adults

By Griesshammer M.   Bangerter M.   Grünewald M.  

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 3, 2001-03 ,pp. : 385-393

Informa Healthcare

Access to resources Recommend Favorite

Essential thrombocythaemia in children: is a treatment needed?

By Randi Maria Luigia   Putti Maria Caterina  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 5, 2004-05 ,pp. : 1009-1014

Informa Healthcare

Access to resources Recommend Favorite

Pharmacotherapy of essential thrombocythaemia: economic considerations

By Griesshammer Martin   Langer Christian  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 9, 2003-09 ,pp. : 1499-1505

Informa Healthcare

Access to resources Recommend Favorite

Anagrelide is an effective platelet-lowering agent, but its role in the treatment of essential thrombocythaemia has yet to be fully determined

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 22, Iss. 11, 2006-11 ,pp. : 1-5

Adis International

Access to resources Recommend Favorite